Product
Ambroxol Hydrochloride
2 clinical trials
5 indications
Indication
PneumoniaIndication
Community-acquired PneumoniaIndication
Nosocomial PneumoniaIndication
Critical IllnessIndication
Parkinson's diseaseClinical trial
A Randomised Controlled Trial to Assess the Efficacy of Intravenous Ambroxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill PatientsStatus: Completed, Estimated PCD: 2023-10-31
Clinical trial
Ambroxol to Slow Progression in Parkinson Disease: A Phase IIIa Multi-centre Randomised Placebo-controlled TrialStatus: Not yet recruiting, Estimated PCD: 2027-03-01